vs
Churchill Downs Inc（CHDN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Churchill Downs Inc的季度营收约是Royalty Pharma plc的1.1倍（$663.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 12.5%，领先21.9%），Royalty Pharma plc同比增速更快（4.8% vs 3.1%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -13.7%）
丘吉尔唐斯股份有限公司是丘吉尔唐斯赛马场的母公司，起家于美国肯塔基州路易斯维尔的单一赛马场，现已发展为业务覆盖美国多州的上市企业，旗下拥有赛马场、赌场、线上投注平台等多元业务板块。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CHDN vs RPRX — 直观对比
营收规模更大
CHDN
是对方的1.1倍
$622.0M
营收增速更快
RPRX
高出1.7%
3.1%
净利率更高
RPRX
高出21.9%
12.5%
两年增速更快
RPRX
近两年复合增速
-13.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $663.0M | $622.0M |
| 净利润 | $83.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 21.6% | 62.4% |
| 净利率 | 12.5% | 34.4% |
| 营收同比 | 3.1% | 4.8% |
| 净利润同比 | 7.8% | 2.9% |
| 每股收益（稀释后） | $1.16 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHDNRPRX
| Q1 26 | $663.0M | — | ||
| Q4 25 | $665.9M | $622.0M | ||
| Q3 25 | $683.0M | $609.3M | ||
| Q2 25 | $934.4M | $578.7M | ||
| Q1 25 | $642.6M | $568.2M | ||
| Q4 24 | $624.2M | $593.6M | ||
| Q3 24 | $628.5M | $564.7M | ||
| Q2 24 | $890.7M | $537.3M |
净利润CHDNRPRX
| Q1 26 | $83.0M | — | ||
| Q4 25 | $51.3M | $214.2M | ||
| Q3 25 | $38.1M | $288.2M | ||
| Q2 25 | $216.9M | $30.2M | ||
| Q1 25 | $76.7M | $238.3M | ||
| Q4 24 | $71.7M | $208.2M | ||
| Q3 24 | $65.4M | $544.0M | ||
| Q2 24 | $209.3M | $102.0M |
营业利润率CHDNRPRX
| Q1 26 | 21.6% | — | ||
| Q4 25 | 18.5% | 62.4% | ||
| Q3 25 | 14.3% | 70.1% | ||
| Q2 25 | 35.1% | 36.3% | ||
| Q1 25 | 20.9% | 94.0% | ||
| Q4 24 | 20.3% | 60.9% | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 37.0% | 50.2% |
净利率CHDNRPRX
| Q1 26 | 12.5% | — | ||
| Q4 25 | 7.7% | 34.4% | ||
| Q3 25 | 5.6% | 47.3% | ||
| Q2 25 | 23.2% | 5.2% | ||
| Q1 25 | 11.9% | 41.9% | ||
| Q4 24 | 11.5% | 35.1% | ||
| Q3 24 | 10.4% | 96.3% | ||
| Q2 24 | 23.5% | 19.0% |
每股收益（稀释后）CHDNRPRX
| Q1 26 | $1.16 | — | ||
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $200.0M | $618.7M |
| 总债务越低越好 | $840.0M | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $7.5B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CHDNRPRX
| Q1 26 | $200.0M | — | ||
| Q4 25 | $200.6M | $618.7M | ||
| Q3 25 | $180.5M | $938.9M | ||
| Q2 25 | $182.4M | $631.9M | ||
| Q1 25 | $174.2M | $1.1B | ||
| Q4 24 | $175.5M | $929.0M | ||
| Q3 24 | $152.7M | $950.1M | ||
| Q2 24 | $140.3M | $1.8B |
总债务CHDNRPRX
| Q1 26 | $840.0M | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益CHDNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $9.7B | ||
| Q3 25 | $1.0B | $9.6B | ||
| Q2 25 | $1.0B | $9.5B | ||
| Q1 25 | $1.1B | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.1B | $10.3B | ||
| Q2 24 | $1.0B | $9.8B |
总资产CHDNRPRX
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.5B | $19.6B | ||
| Q3 25 | $7.5B | $19.3B | ||
| Q2 25 | $7.4B | $18.3B | ||
| Q1 25 | $7.3B | $17.6B | ||
| Q4 24 | $7.3B | $18.2B | ||
| Q3 24 | $7.2B | $18.0B | ||
| Q2 24 | $7.2B | $17.7B |
负债/权益比CHDNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $295.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.55× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHDNRPRX
| Q1 26 | $295.0M | — | ||
| Q4 25 | — | $827.1M | ||
| Q3 25 | $187.7M | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | $246.5M | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | $169.4M | $703.6M | ||
| Q2 24 | — | $658.2M |
自由现金流CHDNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $166.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $233.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $154.4M | — | ||
| Q2 24 | — | — |
自由现金流率CHDNRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 36.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | — | — |
资本支出强度CHDNRPRX
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 2.5% | — |
现金转化率CHDNRPRX
| Q1 26 | 3.55× | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | 4.93× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 3.21× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 2.59× | 1.29× | ||
| Q2 24 | — | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHDN
| Live and Historical Racing | $297.0M | 45% |
| Gaming | $257.0M | 39% |
| Wagering Services and Solutions | $109.0M | 16% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
